ctDNA clearance and outcomes for resectable lung cancer from NeoCOAST-2

Nature作者:Lara McGrath2026年10月25日查看原文 ↗
  • Translational Medicine, Oncology R&D, AstraZeneca, Cambridge, MA, USA

    Lara McGrath

  • Translational Medicine, Early Data Science, Oncology R&D, AstraZeneca, Cambridge, UK

    Gozde Kar

  • Department of Surgery, Oncology and Gastroenterology, University of Padova, Padova, Italy

    Laura Bonanno

  • Medical Oncology 2, Istituto Oncologico Veneto IRCCS, Padova, Italy

    Laura Bonanno

  • Univ Rouen Normandie, LITIS Lab QuantIF team EA4108, CHU Rouen, Department of Pneumology and Inserm CIC-CRB 1404, Rouen, France

    Florian Guisier

  • Medical Oncology Department, Hospital Clínico Universitario de Valencia, Valencia, Spain

    Amelia Insa

  • Division of Thoracic Surgery, University of Montréal, Montréal, Quebec, Canada

    Moishe Liberman

  • CETOC - CHUM Endoscopic Tracheobronchial and Oesophageal Center, Centre Hospitalier de l’Université de Montréal, Montreal, Quebec, Canada

    Moishe Liberman

  • Pneumology Department, Hôpital d’Instruction des Armées Sainte-Anne, Toulon, France

    Olivier Bylicki

  • Department of Radiation Oncology, University of Florence, Florence, Italy

    Lorenzo Livi

  • Department of Thoracic Oncology, Dupuytren University Hospital, Limoges, France

    Thomas Egenod

  • Department of Medical Oncology, CH de Cornouaille, Quimper, France

    Romain Corre

  • Department of Internal Medicine, Seoul National University College of Medicine and Seoul National Hospital, Seoul, South Korea

    Dong-Wan Kim

  • Hospital de A Coruña, Sergas, A Coruña, Spain

    Maria Rosario Garcia Campelo

  • Puerta de Hierro University Hospital, Majadahonda, Spain

    Mariano Provencio Pulla

  • Department of Medical Oncology, The Catholic University of Korea, St. Vincent’s Hospital, Seoul, South Korea

    Byoung Yong Shim

  • Santa Maria della Misericordia Hospital, University of Perugia, Perugia, Italy

    Giulio Metro

  • Department of Medical Oncology, Hôpital Foch, Suresnes, France

    Jaafar Bennouna

  • Early Clinical Development, Oncology R&D, AstraZeneca, Cambridge, MA, USA

    Agata A. Bielska & Italia Grenga

  • Early Clinical Development, Oncology R&D, AstraZeneca, Gaithersburg, MD, USA

    Alula R. Yohannes & Joanna Shaju

  • Early Oncology Biometrics, Oncology R&D, AstraZeneca, Cambridge, MA, USA

    Yun He

  • Early Clinical Programs, Oncology R&D, AstraZeneca, Cambridge, UK

    Adam Dowson

  • Department of Thoracic Surgery, McGill University, Montreal, Quebec, Canada

    Jonathan Spicer

  • Trinity St. James’s Cancer Institute, School of Medicine, Trinity College Dublin, Dublin, Ireland

    Patrick M. Forde

  • Department of Thoracic-Head & Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA

    Tina Cascone